Literature DB >> 1371939

High-dose aprotinin therapy: a review of the first five years' experience.

D Royston1.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1371939     DOI: 10.1016/1053-0770(91)90052-u

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  16 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels.

Authors:  Ramya Thota; Apar Kishor Ganti; Shanmuga Subbiah
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 3.  Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.

Authors:  J F Hardy; S Bélisle
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

4.  Use of aprotinin to reduce intraoperative bleeding.

Authors:  T W Feeley; L A Rinsky
Journal:  West J Med       Date:  1993-08

5.  Hyperfibrinolysis.

Authors:  B J Hunt; H Segal
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

Review 6.  A risk-benefit assessment of aprotinin in cardiac surgical procedures.

Authors:  W B Dobkowski; J M Murkin
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 7.  Antifibrinolytic therapy in cardiac surgery.

Authors:  R H Chen; O H Frazier; D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

Review 8.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.

Authors:  J F Hardy; J Desroches; S Belisle; J Perrault; M Carrier; D Robitaille
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

10.  Aprotinin concentration varies significantly according to cardiopulmonary bypass conditions.

Authors:  T Okamura; N Ishibashi; Y Iwata; D Zurakowski; R A Jonas
Journal:  Perfusion       Date:  2008-11       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.